Table 1 Relationship between CTD-2547G23.4 expression and clinical parameters in TCGA
Clinicopathological feature | n | CTD-2547G23.4 expression in TCGA database | ||
|---|---|---|---|---|
M ± SD | t | P | ||
Tissue | ||||
 Adjacent non-tumour tissues | 50 | 14.5111 ± 8.3412 | 18.571 | 0.000 |
 HCC | 370 | 48.7622 ± 27.2703 | ||
Gender | ||||
 Male | 248 | 47.0800 ± 25.2880 | 1.696 | 0.091 |
 Female | 122 | 52.1820 ± 30.7392 | ||
Neoplasm histologic grade | ||||
 G1 + G2 | 232 | 45.7392 ± 26.5334 | − 3.028 | 0.003 |
 G3 + G4 | 134 | 54.6165 ± 27.8375 | ||
Pathologic stage | ||||
 Stage I–II | 259 | 48.5259 ± 27.5527 | − 0.779 | 0.437 |
 Stage III–IV | 87 | 51.1969 ± 28.0238 | ||
Pathologic tumour | ||||
 TI–II | 273 | 48.7915 ± 27.3716 | − 0.114 | 0.910 |
 TIII–IV | 93 | 49.1656 ± 27.4492 | ||
Pathologic lymph node | ||||
 No | 252 | 48.7484 ± 28.3941 | 0.896 | 0.148 |
 Yes | 4 | 69.5526 ± 31.8511 | ||
Metastasis | ||||
 No | 266 | 48.5517 ± 27.1714 | 1.041 | 0.299 |
 Yes | 4 | 34.3420 ± 19.3781 | ||
Person neoplasm cancer status | ||||
 Tumour free | 202 | 46.8598 ± 26.3441 | − 1.774 | 0.077 |
 With tumour | 150 | 52.1074 ± 28.8736 | ||
Vascular tumour cell type | ||||
 Negative | 205 | 45.8987 ± 25.3009 | 0.045 | 0.028 |
 Positive | 110 | 53.5897 ± 31.4477 | ||